Business Context and Reporting Period
Company: Axiom Intelligence Acquisition Corp 1 (SPAC)
Filing Type: Form 8-K (Current Report)
Date of Report: June 9, 2026
Event: Disclosure of a Business Combination Agreement entered into on May 25, 2026, with Terra Quantum AG, a Swiss company specializing in quantum computing, quantum security, and AI-driven optimization solutions. The transaction involves the formation of a new public entity ("PubCo") organized under Swiss law.
Key Financial Metrics
This filing is a disclosure of a proposed transaction and does not contain audited financial statements, revenue, profit, cash flow, or margin data for the reporting period.
- Revenue/Profit: Not provided in this filing.
- Debt/Liquidity: Specific figures are not provided. The filing notes that the amount of funds available depends on shareholder redemption requests from the SPAC trust account.
- Trading Symbols: Units (AXINU), Class A Ordinary Shares (AXIN), Rights (AXINR) on The Nasdaq Stock Market LLC.
Material Changes and Transaction Details
The primary material change is the execution of the Business Combination Agreement with Terra Quantum AG. Key aspects include:
- Parties: Axiom Intelligence Acquisition Corp 1, Terra Quantum AG, and various shareholder representatives.
- Structure: The combination will result in a new public limited company organized under the laws of Switzerland.
- Regulatory Status: The transaction is subject to shareholder approval from both the SPAC and the Company, as well as potential regulatory approvals.
- Documentation: An Investor Deck Presentation (Exhibit 99.1) is attached and incorporated by reference for investor presentations.
Guidance, Outlook, and Risks
Outlook: The filing contains extensive forward-looking statements regarding the potential benefits, market size, and growth opportunities of the combined entity. Management anticipates the transaction will proceed pending approvals, but explicitly disclaims any obligation to update these projections.
Material Risks and Contingencies:
- Transaction Failure: Risk that the Business Combination is not consummated due to lack of regulatory approval, shareholder rejection, or failure to meet conditions.
- Redemptions: Uncertainty regarding the amount of redemption requests by SPAC shareholders, which directly impacts the cash available to the combined company.
- Listing Risk: Potential inability to maintain or obtain a listing for PubCo securities on Nasdaq.
- Technology and Market Risks: Risks associated with the emerging quantum technology industry, including market adoption, technological feasibility, rapid technological change, and competition.
- Operational Risks: Challenges in managing growth, retaining key scientific talent, and protecting intellectual property.
Investor Verification Checklist
- Verify the final terms of the Business Combination Agreement once the definitive proxy statement/prospectus is filed.
- Monitor the level of shareholder redemption requests to assess the final cash balance available to Terra Quantum AG.
- Review the "Risk Factors" section in the upcoming Form F-4 Registration Statement for detailed disclosures on quantum technology risks.
- Confirm the status of regulatory approvals required for the cross-border merger between a Cayman SPAC and a Swiss target.
- Check for the filing of the definitive proxy statement to understand the voting requirements and timeline for shareholder approval.